Estimated Absorbed Dose from 201Tl as Thallous Chloride Plus Contaminants After Intravenous Administration, Allowing for Shelf Life of 5 Days After Calibration (Assumed Percentages of 201Tl, 202Tl, and 203Pb: 0.9707, 0.0280, 0.0013; Contribution of 200Tl Is Effectively Zero and Is Not Included) and Percent Contribution of Each Radioisotope to Absorbed Dose
| Organ | Estimated radiation dose | % contribution | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| rad/mCi | mGy/MBq, | |||||||||||||
| 201Tl | 202Tl | 203Pb | Total | Total | 201Tl | 202Tl | 203Pb | |||||||
| Adrenals | 2.07E−01 | 4.99E−02 | 5.42E−04 | 2.58E−01 | 6.96E−02 | 80.41 | 19.38 | 0.21 | ||||||
| Brain | 1.88E−01 | 4.14E−02 | 2.18E−04 | 2.30E−01 | 6.22E−02 | 81.91 | 17.99 | 0.09 | ||||||
| Breasts | 1.13E−01 | 2.25E−02 | 1.53E−04 | 1.36E−01 | 3.67E−02 | 83.34 | 16.55 | 0.11 | ||||||
| GB wall | 2.72E−01 | 6.53E−02 | 6.56E−04 | 3.38E−01 | 9.13E−02 | 80.47 | 19.33 | 0.19 | ||||||
| LLI wall | 1.03E+00 | 1.06E−01 | 2.08E−04 | 1.14E+00 | 3.07E−01 | 90.70 | 9.28 | 0.02 | ||||||
| Small intestine | 1.32E+00 | 1.24E−01 | 2.39E−04 | 1.45E+00 | 3.92E−01 | 91.41 | 8.57 | 0.02 | ||||||
| Stomach wall | 5.88E−01 | 8.09E−02 | 2.34E−04 | 6.69E−01 | 1.81E−01 | 87.87 | 12.09 | 0.03 | ||||||
| ULI wall | 1.02E+00 | 1.31E−01 | 2.65E−04 | 1.15E+00 | 3.12E−01 | 88.62 | 11.36 | 0.02 | ||||||
| Heart wall | 8.64E−01 | 8.15E−02 | 2.80E−04 | 9.45E−01 | 2.55E−01 | 91.35 | 8.62 | 0.03 | ||||||
| Kidneys | 1.43E+00 | 1.41E−01 | 1.09E−03 | 1.57E+00 | 4.25E−01 | 90.97 | 8.97 | 0.07 | ||||||
| Liver | 3.15E−01 | 5.35E−02 | 1.96E−03 | 3.70E−01 | 1.00E−01 | 85.01 | 14.46 | 0.53 | ||||||
| Lungs | 1.57E−01 | 3.27E−02 | 3.02E−04 | 1.90E−01 | 5.14E−02 | 82.67 | 17.17 | 0.16 | ||||||
| Muscle | 1.52E−01 | 3.36E−02 | 2.41E−04 | 1.85E−01 | 5.01E−02 | 81.74 | 18.13 | 0.13 | ||||||
| Ovaries | 3.34E−01 | 7.92E−02 | 2.23E−04 | 4.13E−01 | 1.12E−01 | 80.78 | 19.16 | 0.05 | ||||||
| Pancreas | 2.46E−01 | 6.00E−02 | 4.30E−04 | 3.07E−01 | 8.29E−02 | 80.30 | 19.56 | 0.14 | ||||||
| Red marrow | 1.43E−01 | 3.93E−02 | 8.49E−04 | 1.83E−01 | 4.94E−02 | 78.03 | 21.51 | 0.46 | ||||||
| Bone surface | 3.14E−01 | 4.82E−02 | 4.41E−03 | 3.66E−01 | 9.90E−02 | 85.65 | 13.15 | 1.20 | ||||||
| Skin | 1.06E−01 | 2.05E−02 | 1.59E−04 | 1.26E−01 | 3.41E−02 | 83.64 | 16.23 | 0.13 | ||||||
| Spleen | 5.67E−01 | 8.43E−02 | 2.07E−04 | 6.51E−01 | 1.76E−01 | 87.03 | 12.94 | 0.03 | ||||||
| Testes | 7.29E−01 | 7.35E−02 | 1.43E−04 | 8.03E−01 | 2.17E−01 | 90.82 | 9.16 | 0.02 | ||||||
| Thymus | 1.52E−01 | 3.31E−02 | 1.92E−04 | 1.86E−01 | 5.02E−02 | 82.08 | 17.82 | 0.10 | ||||||
| Thyroid | 1.92E+00 | 1.34E−01 | 1.85E−04 | 2.05E+00 | 5.54E−01 | 93.45 | 6.54 | 0.01 | ||||||
| UB wall | 2.07E−01 | 4.61E−02 | 1.66E−04 | 2.53E−01 | 6.84E−02 | 81.70 | 19.23 | 0.07 | ||||||
| Uterus | 2.84E−01 | 6.70E−02 | 1.98E−04 | 3.52E−01 | 9.49E−02 | 80.87 | 19.07 | 0.06 | ||||||
| Total body | 1.93E−01 | 3.70E−02 | 3.97E−04 | 2.31E−01 | 6.23E−02 | 83.76 | 16.07 | 0.17 | ||||||
| Effective dose | % contribution | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| rem/mCi | mSv/MBq, | ||||||||||||
| 5.36E−01 | 6.31E−02 | 4.07E−04 | 5.99E−01 | 1.62E−01 | 89.40 | 10.50 | 0.068 | ||||||
GB = gallbladder; LLI = lower large intestine; ULI = upper large intestine; UB = urinary bladder.
Effective dose and percent contribution to effective dose for each radioisotope are provided at bottom of table.